AI promises to accelerate scientific discovery, but if scientists aren't careful public trust may be left behind.

Looking at Firefly’s year-to-date (YTD) performance, the company has shown an incredible gain of +38.49%. In comparison, the broader market, as represented by the S&P 500, is down -1.61% YTD. This ...

Introduction - The year 2024 marked a pivotal time in artificial intelligence, where aspirations transformed into concrete ...

As neuro-AI research advances, it holds the potential to revolutionize our understanding of intelligence by seamlessly ...

Greg Lipschitz, Executive Chairman of Firefly, said, “This breakthrough underscores our commitment to pushing the boundaries of innovation in brain health, ultimately with the aim of making a ...

Researchers have developed an AI model that accurately predicts gene activity in any human cell, providing insights into cellular functions and disease mechanisms.

An AI-powered algorithm could facilitate the diagnosis of a common sleep disorder that affects over 80 million people globally. | Neuroscience ...

Firefly Neuroscience shares doubled to $3.90 Tuesday after the company said it is advancing its research used to assess a patient's brain age--an estimation of the biological age of a person's ...

Researchers have developed a Genetic Progression Score (GPS) using artificial intelligence to predict the progression of autoimmune diseases from preclinical symptoms to full disease.

BrainSight AI raised $5 million in pre-series A funding round. With plans to expand in India and pursue FDA certification.